Earth Science Tech, Inc. (OTC: ETST) reported a 57% year-over-year increase in net income for its fiscal first quarter of 2027, according to a press release issued today. The company posted net income of $715,697, up from the prior-year period, on revenue of $9.0 million, a 3% increase. Gross profit climbed to $6.3 million, while operating cash flow more than doubled to $707,131. Total assets rose to $10.4 million, and diluted earnings per share improved to $0.003 from $0.001.
The company also announced that it repurchased and retired more than 3.7 million common shares during the quarter without incurring additional debt. This move is part of a broader strategy to enhance shareholder value, as the company continues to strengthen its financial position. “All key operating subsidiaries remained profitable,” the company stated, as it expands the licensing footprint of its compounding pharmacy operations across the United States. Earth Science Tech is also evaluating opportunities to broaden its telehealth and pharmacy fulfillment platforms, aiming to capitalize on the growing demand for integrated healthcare services.
The results underscore the company’s operational resilience and its ability to generate sustainable growth in a competitive market. The increase in net income and cash flow provides a solid foundation for future investments and strategic initiatives. For investors, the strong quarterly performance signals that Earth Science Tech is executing effectively on its business plan, which could lead to improved market confidence and liquidity.
Management will discuss these results and strategic initiatives at the annual shareholder meeting scheduled for Aug. 31, 2026. At the meeting, shareholders will vote on proposals including the cancellation of the company’s Series B Preferred Stock, a move that could simplify the capital structure. Additionally, the company will provide updates on a potential exchange uplisting, which aims to improve liquidity and market visibility. An uplisting to a major exchange like NASDAQ or NYSE could attract institutional investors and increase trading volume, potentially benefiting all shareholders.
The company’s diversified holding structure, which integrates compounding pharmacy, telemedicine, and direct-to-patient fulfillment, positions it well to capture synergies in the health and wellness sector. By combining these operations, Earth Science Tech can offer a seamless patient experience from consultation to delivery, a competitive advantage in an increasingly digital healthcare landscape.
Investors can access the full press release for more details at https://ibn.fm/WHicW. For the latest news and updates on Earth Science Tech, visit the company’s newsroom at https://ibn.fm/ETST.
